ISA Pharmaceuticals ▲ Sign in to save

• ▲ Cornelis J.M. Melief

  ISA Pharmaceuticals (Netherlands) Immunology and Microbiology
  33.1k

  citations

  87

  h-index

  28

  Aachen papers
• ▲ Cornelis J.M. Melief

  Immunology and Microbiology
  11.5k

  citations

  44

  h-index

  2

  Aachen papers
• ▲ Cornelis J.M. Melief

  Immunology and Microbiology
  10.4k

  citations

  44

  h-index

  4

  Aachen papers
• ▲ Willem-Jan Krebber

  ISA Pharmaceuticals (Netherlands) Immunology and Microbiology
  2.98k

  citations

  10

  h-index

  9

  Aachen papers
• ▲ Leon W. Hooftman

  ISA Pharmaceuticals (Netherlands) Biochemistry, Genetics and Molecular Biology
  2.7k

  citations

  18

  h-index

  7

  Aachen papers
• ▲ Anna‐Sophia Wiekmeijer

  ISA Pharmaceuticals (Netherlands) Immunology and Microbiology
  679

  citations

  10

  h-index

  8

  Aachen papers
• ▲ Kitty Kwappenberg

  ISA Pharmaceuticals (Netherlands) Medicine
  523

  citations

  2

  h-index

  1

  Aachen papers
• ▲ Sonja Visscher

  Medicine
  503

  citations

  6

  h-index

  4

  Aachen papers
• ▲ Thomas J. M. Beenakker

  ISA Pharmaceuticals (Netherlands) Chemistry
  457

  citations

  13

  h-index

  9

  Aachen papers
• ▲ Esmé T.I. van der Gracht

  ISA Pharmaceuticals (Netherlands) Immunology and Microbiology
  380

  citations

  11

  h-index

  13

  Aachen papers
• ▲ Johan L. van der Plas

  ISA Pharmaceuticals (Netherlands) Medicine
  170

  citations

  7

  h-index

  10

  Aachen papers
• ▲ Ghislaine Meiners

  ISA Pharmaceuticals (Netherlands) Immunology and Microbiology
  56

  citations

  1

  h-index

  1

  Aachen papers
• ▲ Peter van Rijn

  ISA Pharmaceuticals (Netherlands) Medicine
  0

  citations

  0

  h-index

  1

  Aachen papers

13 results

• Therapeutic cancer vaccines

  2021 Nature reviews. Cancer review Immunology and Microbiology Immunotherapy and Immune Responses cited by 15 patents

  1,576

  citations
• Strong vaccine responses during chemotherapy are associated with prolonged cancer survival

  2020 Science Translational Medicine article Immunology and Microbiology Immunotherapy and Immune Responses Open access cited by 2 patents

  136

  citations
• Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention

  2020 Toxicology Reports article Medicine COVID-19 Clinical Research Studies Open access cited by 1 patent

  98

  citations
• ISA101 and nivolumab for HPV-16 + cancer: updated clinical efficacy and immune correlates of response

  2022 Journal for ImmunoTherapy of Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access

  98

  citations
• Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses

  2020 Journal for ImmunoTherapy of Cancer article Immunology and Microbiology Immunotherapy and Immune Responses Open access cited by 1 patent

  56

  citations
• Peptide emulsions in incomplete Freund’s adjuvant create effective nurseries promoting egress of systemic CD4+ and CD8+ T cells for immunotherapy of cancer

  2022 Journal for ImmunoTherapy of Cancer article Immunology and Microbiology Immunotherapy and Immune Responses Open access cited by 2 patents

  42

  citations
• Targeting the PD-1/PD-L1 Axis in Human Vitiligo

  2020 Frontiers in Immunology article Biochemistry, Genetics and Molecular Biology melanin and skin pigmentation Open access cited by 1 patent

  32

  citations
• IFN‐γ‐induced PD‐L1 expression on human melanocytes is impaired in vitiligo

  2021 Experimental Dermatology article Biochemistry, Genetics and Molecular Biology melanin and skin pigmentation Open access

  22

  citations
• Special Review: The future of Immunotherapy

  2020 Immunotherapy Advances article Medicine Cancer Immunotherapy and Biomarkers Open access

  11

  citations
• Cemiplimab plus peltopepimut-S vaccine in recurrent cervical cancer: A phase 2 clinical trial

  2025 Gynecologic Oncology article Medicine Cervical Cancer and HPV Research Open access

  10

  citations
• Editorial: Novel Strategies for Anti-Tumor Vaccines

  2020 Frontiers in Immunology editorial Immunology and Microbiology Immunotherapy and Immune Responses Open access

  9

  citations
• Delayed vaccine-induced CD8+ T cell expansion by topoisomerase I inhibition mediates enhanced CD70-dependent tumor eradication

  2023 Journal for ImmunoTherapy of Cancer article Immunology and Microbiology Immunotherapy and Immune Responses Open access

  7

  citations
• Combination immunotherapy with synthetic long peptides and chemotherapy or PD-1 blocker for cancers caused by human papilloma virus type 16

  2023 Seminars in Immunopathology article Immunology and Microbiology Immunotherapy and Immune Responses

  6

  citations
• Combination of cemiplimab and ISA101b vaccine for the treatment of recurrent/metastatic HPV16 cervical cancer.

  2024 Journal of Clinical Oncology conference-abstract Medicine Cervical Cancer and HPV Research

  5

  citations
• Two types of biomarker-dependent chemo-immunotherapy for pancreatic cancer?

  2022 Cell Reports Medicine article Medicine Pancreatic and Hepatic Oncology Research Open access

  1

  citations
• List of contributors

  2022 Elsevier eBooks paratext

  0

  citations
• Therapeutic cancer vaccines targeting viral antigens

  2022 Elsevier eBooks book-chapter Immunology and Microbiology Immunotherapy and Immune Responses

  0

  citations
• T cell-mediated protection against lethal SARS-CoV-2 challenge by a synthetic long peptide vaccine targeting conserved CD4+ and CD8+ T cell epitopes

  2026 Research Square preprint Medicine SARS-CoV-2 and COVID-19 Research Open access

  0

  citations

18 results